Migdal Insurance & Financial Holdings’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,432	Closed	-$2K	–	671
2021 Q4	$2K	Sell	2,432 -1,568	-39%	-$1.29K	﹤0.01%	668
2021 Q3	$5K	Buy	+4,000	New	+$5K	﹤0.01%	634